Literature DB >> 33674641

Single-cell differential splicing analysis reveals high heterogeneity of liver tumor-infiltrating T cells.

Shang Liu1,2,3, Biaofeng Zhou1,2,3, Liang Wu1,2,3, Yan Sun1,2,3, Jie Chen1,2, Shiping Liu4,5.   

Abstract

Recent advances in single-cell RNA sequencing (scRNA-seq) have improved our understanding of the association between tumor-infiltrating lymphocyte (TILs) heterogeneity and cancer initiation and progression. However, studies investigating alternative splicing (AS) as an important regulatory factor of heterogeneity remain limited. Here, we developed a new computational tool, DESJ-detection, which accurately detects differentially expressed splicing junctions (DESJs) between cell groups at the single-cell level. We analyzed 5063 T cells of hepatocellular carcinoma (HCC) and identified 1176 DESJs across 11 T cell subtypes. Interestingly, DESJs were enriched in UTRs, and have putative effects on heterogeneity. Cell subtypes with a similar function closely clustered together at the AS level. Meanwhile, we identified a novel cell state, pre-activation with the isoform markers ARHGAP15-205. In summary, we present a comprehensive investigation of alternative splicing differences, which provided novel insights into T cell heterogeneity and can be applied to other full-length scRNA-seq datasets.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33674641      PMCID: PMC7935992          DOI: 10.1038/s41598-021-84693-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  35 in total

1.  Analysis and design of RNA sequencing experiments for identifying isoform regulation.

Authors:  Yarden Katz; Eric T Wang; Edoardo M Airoldi; Christopher B Burge
Journal:  Nat Methods       Date:  2010-11-07       Impact factor: 28.547

2.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

3.  Single-Cell Alternative Splicing Analysis with Expedition Reveals Splicing Dynamics during Neuron Differentiation.

Authors:  Yan Song; Olga B Botvinnik; Michael T Lovci; Boyko Kakaradov; Patrick Liu; Jia L Xu; Gene W Yeo
Journal:  Mol Cell       Date:  2017-06-29       Impact factor: 17.970

4.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

5.  Compensatory relationship between splice sites and exonic splicing signals depending on the length of vertebrate introns.

Authors:  Colin N Dewey; Igor B Rogozin; Eugene V Koonin
Journal:  BMC Genomics       Date:  2006-12-08       Impact factor: 3.969

6.  Design of RNA splicing analysis null models for post hoc filtering of Drosophila head RNA-Seq data with the splicing analysis kit (Spanki).

Authors:  David Sturgill; John H Malone; Xia Sun; Harold E Smith; Leonard Rabinow; Marie-Laure Samson; Brian Oliver
Journal:  BMC Bioinformatics       Date:  2013-11-09       Impact factor: 3.169

7.  Single-cell mRNA quantification and differential analysis with Census.

Authors:  Xiaojie Qiu; Andrew Hill; Jonathan Packer; Dejun Lin; Yi-An Ma; Cole Trapnell
Journal:  Nat Methods       Date:  2017-01-23       Impact factor: 28.547

8.  IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3.

Authors:  Reiner K W Mailer; Anne-Laure Joly; Sang Liu; Szabolcs Elias; Jesper Tegner; John Andersson
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

9.  Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.

Authors:  Xiwen Liao; Ketuan Huang; Rui Huang; Xiaoguang Liu; Chuangye Han; Long Yu; Tingdong Yu; Chengkun Yang; Xiangkun Wang; Tao Peng
Journal:  Onco Targets Ther       Date:  2017-09-12       Impact factor: 4.147

10.  VALERIE: Visual-based inspection of alternative splicing events at single-cell resolution.

Authors:  Wei Xiong Wen; Adam J Mead; Supat Thongjuea
Journal:  PLoS Comput Biol       Date:  2020-09-08       Impact factor: 4.475

View more
  6 in total

Review 1.  Sequence determinants as key regulators in gene expression of T cells.

Authors:  Benoit P Nicolet; Nordin D Zandhuis; V Maria Lattanzio; Monika C Wolkers
Journal:  Immunol Rev       Date:  2021-09-05       Impact factor: 10.983

Review 2.  Post-transcriptional control of T-cell cytokine production: Implications for cancer therapy.

Authors:  Julian J Freen-van Heeren
Journal:  Immunology       Date:  2021-05-10       Impact factor: 7.215

Review 3.  Alternative RNA splicing in tumour heterogeneity, plasticity and therapy.

Authors:  Sebastian Öther-Gee Pohl; Kevin B Myant
Journal:  Dis Model Mech       Date:  2022-01-11       Impact factor: 5.758

4.  Robust and annotation-free analysis of alternative splicing across diverse cell types in mice.

Authors:  Gonzalo Benegas; Jonathan Fischer; Yun S Song
Journal:  Elife       Date:  2022-03-01       Impact factor: 8.713

Review 5.  Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope.

Authors:  Weili Jia; Tianchen Zhang; Qianyun Yao; Jianhui Li; Ye Nie; Xinjun Lei; Zhenzhen Mao; Yanfang Wang; Wen Shi; Wenjie Song
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 6.  Exploiting Single-Cell Tools in Gene and Cell Therapy.

Authors:  Daniel Bode; Alyssa H Cull; Juan A Rubio-Lara; David G Kent
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.